Breast cancer iTME constituents possess the ability to reprogram tumor growth and distant metastasis; hence, a better understanding of the iTME would help in designing effective approaches for efficient targeting of S100A7-overexpressing metastatic breast cancers. This evidence concerns the gene S100A7 and breast cancer.